Preclinical and clinical evidence for suppression of alcohol intake by apremilast-Reference-Cited by-同舟云学术

Preclinical and clinical evidence for suppression of alcohol intake by apremilast

Published:2023-03-15 Issue:6 Volume:133 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Grigsby Kolter B.,Mangieri Regina A.^ORCID,Roberts Amanda J.^ORCID,Lopez Marcelo F.,Firsick Evan J.,Townsley Kayla G.^ORCID,Beneze Alan,Bess Jessica,Eisenstein Toby K.,Meissler Joseph J.,Light John M.^ORCID,Miller Jenny,Quello Susan,Shadan Farhad,Skinner Michael,Aziz Heather C.^ORCID,Metten Pamela^ORCID,Morrisett Richard A.,Crabbe John C.,Roberto Marisa^ORCID,Becker Howard C.,Mason Barbara J.,Ozburn Angela R.^ORCID

Funder

National Institute on Alcohol Abuse and Alcoholism

National Institute on Drug Abuse

US Department of Veterans Affairs Grants

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/159103/files/pdf

Reference58 articles.

1. CDC. Excessive Drinking is Draining the US Economy. https://www.cdc.gov/alcohol/features/excessive-drinking.html Updated April 14, 2022. Accessed January 19, 20238

2. Medications for alcohol use disorders: An overview

3. Neuroimmune Pathways in Alcohol Consumption: Evidence from Behavioral and Genetic Studies in Rodents and Humans

4. The role of neuroimmune signaling in alcoholism

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alcohol, flexible behavior, and the prefrontal cortex: Functional changes underlying impaired cognitive flexibility;Neuropharmacology;2024-12

2. The Predictive Value of Plasma Bioactive Lipids on Craving in Human Volunteers With Alcohol Use Disorder;Biological Psychiatry Global Open Science;2024-11

3. The PDE4 inhibitor apremilast modulates ethanol responses in Gabrb1-S409A knock-in mice via PKA-dependent and independent mechanisms;Neuropharmacology;2024-10

4. A novel phosphodiesterase inhibitor for the treatment of chronic liver injury and metabolic diseases;Hepatology;2024-07-01

5. Therapeutic perspectives on PDE4B inhibition in adipose tissue dysfunction and chronic liver injury;Expert Opinion on Therapeutic Targets;2024-06-19